heme has been researched along with atrial natriuretic factor in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boerrigter, G; Burnett, JC; Cataliotti, A; Costello-Boerrigter, LC; Lapp, H; Stasch, JP | 1 |
| Botros, FT; Mitchell, KD; Navar, LG | 1 |
| Jadhav, A; Ndisang, JF | 1 |
| Chibbar, R; Lane, N; Ndisang, JF | 1 |
1 review(s) available for heme and atrial natriuretic factor
| Article | Year |
|---|---|
Intrarenal renin-angiotensin system and counteracting protective mechanisms in angiotensin II-dependent hypertension.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Carbon Monoxide; Cyclooxygenase Inhibitors; Eicosanoids; Heme; Heme Oxygenase (Decyclizing); Hypertension; Hypertension, Renal; Renin-Angiotensin System | 2007 |
3 other study(ies) available for heme and atrial natriuretic factor
| Article | Year |
|---|---|
Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure.
Topics: Animals; Atrial Natriuretic Factor; Benzoates; Blood Vessels; Cardiovascular System; Dogs; Dose-Response Relationship, Drug; Guanylate Cyclase; Heart Failure; Heme; Kidney; Male; Natriuretic Peptide, Brain; Oxidation-Reduction; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Vasodilation | 2007 |
Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
Topics: Adiponectin; Animals; Arginine; Atrial Natriuretic Factor; Blood Pressure; Blotting, Western; Desoxycorticosterone; Disease Models, Animal; Endothelin-1; Heme; Heme Oxygenase (Decyclizing); Hypertension; Kidney; Kidney Diseases; Male; Mineralocorticoids; Rats; Rats, Sprague-Dawley | 2010 |
Heme oxygenase suppresses markers of heart failure and ameliorates cardiomyopathy in L-NAME-induced hypertension.
Topics: Adiponectin; Aldosterone; Animals; Antioxidants; Arginine; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cardiomyopathies; Cardiotonic Agents; Chemokine CCL2; Chemokine CCL3; Cyclic GMP; Dinoprost; Endothelin-1; Enzyme Induction; Extracellular Matrix Proteins; Heart Failure; Heme; Heme Oxygenase (Decyclizing); Hypertension; Interleukin-1beta; Interleukin-6; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tyrosine | 2014 |